Resmed completes $340M Noctrix takeover

Resmed completes $340M Noctrix takeover is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-06-02

The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.

Source: MedTech Dive